HCV Advocate LogoHCV Advocate Logo
Contact Us Site Map Resources en Espanol
For living Positivley. Being Well
About Hepatitis
News Updates
News Review
Conference reports
News Articles
HCV Advocate Newsletter
Sign up for Email Updates
Community & Support
Resource Library
About Hcsp
 
Bookmark and Share
News Review

HCSP News Review

Top News

Journal Review

Eblast

More Archives

This section offers reader-friendly interpretations of some of the more complex current events in hepatitis C, including medical and scientific advancements. The following articles have been compiled by Alan Franciscus, founder of HCSP and HCVAdvocate.org.

Read current articles posted below, or visit our News Review Archive to read articles from previous years.

This site includes links to files you can view online or print. To download and print information, you will need the latest version of Adobe Acrobat Reader. Download it free.

 

Top News 2012

Triple therapy with boceprevir improved SVR among HCV patients with fibrosis, cirrhosis
December 31

2012 Roundup—HCV Treatments
December 28

Doc whose Fremont clinic infected patients with hepatitis seeks N.Y. license to practice
December 27

Trying to halt hepatitis C's molecular hijacking
December 27

Patient Survival Rises When Drugs Suppress Hepatitis C in Blood: Study
December 26

Court tosses racketeering charge in hepatitis case, allows other charges against Las Vegas doctor to stand
December 25

Weighing the hepatitis C risk for baby boomers
December 24

4 More Hepatitis C Cases in Maryland Found Related To Infected Worker
December 22

Medivir announces initiation of the second cohort of the interferon-free phase II study combining Simeprevir and sofosbuvir for hepatitis C treatment
December 21

Chronic HCV linked to vitamin A deficiency, nonresponse to antiviral therapy
December 20

One Man's Harrowing Battle With Hepatitis C
December 20

Medivir announces phase III data for Simeprevir demonstrating efficacy and safety in genotype 1 hepatitis C patients
December 20

Incivek (telaprevir) In Combination with Drugs Peginterferon Alfa and Ribavirin (Incivek combination treatment): Drug Safety Communication - Serious Skin Reactions
December 19

Vertex Announces Update to U.S. Prescribing Information for INCIVEK® (telaprevir)
December 19

Fourth Street Clinic provides costly hepatitis C treatments
December 18

Hepatitis C: The Baby Boomer Virus: Lucinda K. Porter RN at TEDxGrassValley
December 18

Experts Propose New Terminology for Hepatitis C Drug Trials New Definitions Intended to Accelerate Innovation in Drug Development
December 17

HIV and Hepatitis C Coinfection Raises Cognitive Impairment Risk for Men
December 17

HIV+ MSM Have 4 Times HCV Risk of HIV-Negative MSM in Meta-Analysis
December 17

Professor Receives $1.6 Million to Study Potential Hepatitis C Drugs
December 14

HCV-Related Transplants Most Needed By Those Born 1941-60
December 14

Why the CDC's new hepatitis C recommendations for boomers are a no-brainer
December 12

Researchers find clue to how Hepatitis C virus harms liver
December 12

Triple therapy has poor safety in cirrhotic hepatitis C
December 11

Abstracts, presentations, posters, and photos from the 2012 National Summit on HIV and Viral Hepatitis Diagnosis, Prevention and Access to Care are now available
December 10

Most People with Hepatitis C Go Untreated, Despite Effective Drugs
December 10

Medicare funding threat lifted: After hep C outbreak, Exeter Hospital now meeting all conditions of participating in program
December 8

Gilead Sciences Leads The Race In Developing A Hepatitis C Pill
December 8

New Interferon Speeds HCV Virologic Responses
December 7

Delivery method, breastfeeding did not impact mother-to-infant HCV transmission risk
December 6

Aging Hepatitis C Population Escalates Demand for Liver Transplantation
December 6

The Medicare Open Enrollment period ends on Friday, December 7, 2012
December 4

Telaprevir and VX-222 pair well in interferon-free regimen, VX-135 on the horizon
December 3

Study results indicate potential link between chronic HCV, depression
December 2

Ex-hospital worker indicted in hepatitis C infections
November 30

Somagenics Holds Back on HCV Clinical Trial Amid Advances by Other Drugmakers
November 30

Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry
November 30

Liver Cancer Spikes Among Spanish Coinfected With HIV, Hepatitis
November 27

Sexual transmission of HCV among monogamous heterosexual couples: The HCV partners study
November 27

Zinc supplement helps hepatitis C
November 27

Less Support for Hepatitis C Testing for Baby Boomers
November 27

Gilead hepatitis C drug shows promise in late-stage trial
November 27

Sharing drug preparation equipment a potential source of hepatitis C transmission
November 27

Gilead Announces Sustained Virologic Response Rate of 78% from Phase 3 Study of Sofosbuvir for Genotype 2/3 Hepatitis C Infected Patients
November 27

Grapefruit Drug Interactions: Fruit Reacts Dangerously With Expanding List Of Medications, Study Says
November 26

Doctors should consider hepatitis C testing: panel
November 26

Devon Nicholson Hep C treatment Chronicles – Week 4 – "Blood Work and Virus Tests"
November 26

Mom, daughter won't let hepatitis C define them
November 25

Update: Local Veterinarian cured of Hepatitis C
November 22

National Summit on HIV and Viral Hepatitis Convenes November 26-28 in Washington With Focus on Accelerating HIV/Hepatitis C Testing and Reducing Disparities in Care
November 21

Triple Therapy Boosts HCV Response After Transplant
November 20

Simeprevir is safe and effective with interferon/ribavirin for hepatitis C patients with cirrhosis
November 19

Nail salons should be regulated to help prevent the spread of infections: report
November 19

Researcher hunts for hepatitis C cure
November 19

Ontario doctors question long wait for hepatitis C drug Incivek
November 19

FDA approves new indication for PROMACTA® (eltrombopag)
November 19

Many Physicians who Treat HCV Have Begun 'Warehousing' and Preparing HCV Patients for the Next Generation of Interferon-Free Treatments to Become Available, According to a Recent BioTrends Report
November 18

Heroin use linked to hepatitis C increase
November 18

KEY PHASE 2 HIV/HCV TRIAL COMMENCED
November 18

Hepatitis C Treatment's Side Effects Can Now Be Studied in the Lab
November 16

Hep C Protease Inhibitor Incivek Is Safe, Effective for HIV Coinfection
November 15

Interferon-free hepatitis C treatment safe, proves effective in up to 63% of patients with cirrhosis
November 15

Sofosbuvir demonstrates high response rate in interferon-free combination with ribavirin and GS-5885
November 15

Promising HCV Combo May Not See Light of Day
November 15

More coinfected patients receiving treatment for acute HCV
November 15

Peginterferon lambda-1a decreases viral load more quickly, safely than alfa-2a in HCV patients
November 15

INCIVEK™ (telaprevir) Now Funded in Alberta and New Brunswick for People with Hepatitis C
November 15

Veterans twice as likely to be infected with chronic hepatitis C
November 14

Abbott Announces Phase 3 Hepatitis C Program Details
November 13

Background liver proliferation linked to noncirrhotic HCC in patients with HCV
November 13

Weight-based ribavirin undertreats African–American HCV patients
November 13

Reducing ribavirin and adding EPO are both good anaemia management strategies for people taking boceprevir
November 13

Berkeley sued by estates of those who die in jail
November 12

Bristol-Myers, Achillion, Idenix show progress with oral hepatitis C drugs Read more: Bristol-Myers, Achillion, Idenix show progress with oral hepatitis C drugs
November 12

Novartis' Certican succeeds in liver transplant trial
November 12

New cohort shows the impact of hepatitis B and hepatitis C on the 'baby boom' generation
November 11

Gilead posts positive results in mid-stage Hepatitis C study
November 11

Abbott hepatitis C drugs bring high cure rates in trial
November 10

Gilead, Abbott Unwrap Dueling Hep C Pill Data
November 10

Boehringer Ingelheim Launches Hepatitis C Online Resource
November 9

Hepatitis C-infected doctor pleads guilty to 55 charges of negligently causing serious injury
November 9

Vertex's Incivek twice-daily dosing schedule insufficient to entice HCV patients waiting for new drugs
November 6

Europe Fails to Screen its Population for Hepatitis
November 6

Maryland confirms first hepatitis C case linked to arrested med tech
November 6

Radio show host calls organ donors heroes K100's Steele in 15th year of new life
November 5

Merck Will Initiate Interferon-Free Phase II Clinical Trials for MK-5172, an Investigational, Once-Daily, Oral Treatment for Chronic Hepatitis C Virus
November 4

Advanced liver disease and hepatic encephalopathy in the elderly
November 2

India revokes Roche hepatitis patent
November 2

FDA Hepatitis Update - Victrelis (boceprevir) labeling update—acute hypersensitivity reaction warning
November 2

Fortune teller: Mice with 'humanized' livers predict HCV drug candidate's behavior in humans
November 1

Vertex Tests Oral HCV Combos with Janssen and GSK
November 1

Living Donors Fare Well Following Liver Transplantation
November 1

Residents to get tested for HIV and hepatitis
October 31

BioCryst drops hep C drug on safety issues
October 31

Liver transplant survival higher among patients with NASH, HBV; lower for HCV, HCC
October 31

African American Women with HIV/HCV Less Likely to Die from Liver Disease
October 31

Hepatitis E vaccine debuts
October 30

HIV+ People Who Acquire Hepatitis C May Have Impaired HCV-specific Interferon Response
October 30

The case for speaking out on HCV
October 28

Few HCV/HBV infections identified in adults with access to care
October 27

Prisoners, hard hit by hepatitis C, decry lack of access to drugs
October 25

Patients with HCV, diabetes at greater risk for liver-related death
October 24

Long live your liver: Here's how
October 24

Primary care physicians miss hepatitis vaccine targets
October 23

State runs out of hepatitis blood test kits [Charleston Daily Mail, W.Va.]
October 23

Connecting Patients With Experimental Drugs
October 22

Antiviral therapy may halve risk of liver cancer after chronic hepatitis C infection
October 22

Don't Fear the Treatment
October 22

Hepatitis C Treatment Adherence Is Important for HIV/HCV Coinfected People
October 22

Low incidence of reinfection with HCV after treatment in active drug users
October 22

High Recurrence Risk for HCC Following Pegylated IFN Alpha-2b Plus Ribavirin
October 22

Unlicensed tattoo artists worrying health district
October 20

Liver cancer patient not wasting time
October 19

Vertex Draws Collaboration Interest For Hepatitis C Combo
October 19

Enanta's Lead Hepatitis C Compound ABT-450 Advances into a Phase 3 Clinical Trial through its Collaboration with Abbott
October 17

Biotron hepatitis treatment looks promising
October 16

BioLineRx Completes Pre-Clinical Development Of BL-8020
October 15

Rapid Tests Accurate in First-Line HCV Screening
October 15

Abbott's Hepatitis C Drugs Clear Virus in 99% of Patients
October 15

Abbott's Investigational Interferon-Free Hepatitis C Treatment Regimen Achieved SVR12 (Observed Data) Rates in 99 Percent of Treatment-Naïve and 93 Percent in Prior Null Responders for Genotype 1 Patients in Phase 2b Study
October 15

ICAAC 2012: Hepatitis C Can Be Successfully Treated in Injection Drugs Users with or without HIV
October 14

Patients with diabetes, chronic HCV at elevated risk for malignancies
October 14

Medical Reports: Hailey's Hope
October 12

Alternative-medicine doctor reprimanded, fined in hepatitis C outbreak
October 12

High testosterone may boost advanced liver disease risk
October 12

Prior alcohol consumption does not impair HCV treatment
October 12

Civil cases against NH hospital at center of hepatitis C outbreak put on hold
October 12

Veteran wins lawsuit over hepatitis infection he got at Fla. VA hospital; several US cases
October 12

Care center offers hepatitis C testing, support
October 11

Tawn Mastrey Foundation Presents/Headbangers Ball Reunion
October 11

Vitamin D deficiency associated with a poorer response to HCV treatment in HIV/HCV-co-infected patients
October 11

No cases found linking Ottawa endoscopy clinic to infections
October 10

Auditor General Jack Wagner Urges General Assembly, Health Dept. to Begin Licensing of Pa. Tattoo Parlors
October 9

New hepatitis C initiative launched in the Bay
October 9

Fighting Hepatitis C
October 9

N.J. health officials say needle exchanges work
October 8

Medicare: Inpatient or Outpatient?
October 5

HCSP Spanish Easy Facts (Datos Sencillos) Updated
October 4

Doctor stands by his actions at forum on hepatitis C study
October 4

IBTS retested more than 15,000 at risk of Anti-D/HCV
October 4

Hemispherx Biopharma Files for Treatment Expansion in Argentina for Alferon N Injection(R) for Hepatitis C
October 1

AMA pushes for safe injecting trial
October 1

The Next Big Thing in Biotech: Hepatitis Drugs
September 29

Don't rule out IFN/ribavirin for HIV patients with hep C cirrhosis: study
September 28

Janssen and Merck & Co share UK Prix Galien for hepatitis C drugs
September 28

VIEW : Intellectual bankruptcy — Syed Kamran Hashmi
September 27

Achillion heralds upbeat hepatitis C results as it rushes through Phase II Read more: Achillion heralds upbeat hepatitis C results as it rushes through Phase II
September 27

Treating Hepatitis C Infection in Prison is Good Public Policy
September 27

Interferon Free HCV Treatment: Simeprevir and ALS-2200 Enter Phase 2 All-oral Studies
September 26

Vertex Announces New Data on ALS-2200 in People With Hepatitis C, Supporting Advancement into Phase 2 All-Oral Studies in 2012; Ends Development of ALS-2158
September 25

Ethicists question doctor's pitch for a hepatitis C drug trial
September 25

Manitoba Adds Victrelis Triple to Pharmacare
September 25

Lawsuit seeks needle exchange programs for prisons
September 25

Kurk, Bradley criticize Hassan for cuts comment
September 22

Centre for Public Health report featured on BBC and ITV
September 21

World Hepatitis Alliance lands see no, hear no, speak no evil record to raise awareness
September 21

Idenix Pharma: Guilty By Association
September 21

Texas Tribune Weekend Insider: Hepatitis in Prison
September 20

A phase IIa interferon free combination hepatitis C trial of Simeprevir (TMC435) and TMC647055 will commence shortly
September 20

UK Research Aims to Reduce Spread of HIV and Hepatitis in Women
September 19

Achillion Back On The Hep C Roller Coaster Of Love
September 19

Trial of hepatitis C drug has deadly outcome for area man
September 18

Diets High in Fructose May Harm Liver in Some, Scientists Warn
September 18

Better Lasers Make Tattoo Removal Easier
September 18

1 more positive test in Hays for hepatitis C
September 16

Hepatitis C: A public health problem with a solution
September 15

Baltimore policeman shot in line of duty survives once again
September 14

Doctor says region needs clinic to help battle Hepatitis C
September 13

Limbrel (Flavocoxid) Linked to Acute Liver Injury
September 13

Lowering Ribavirin Dose During Telaprevir Therapy Does Not Compromise SVR in Patients With HCV
September 13

ICAAC 2012: HCV Polymerase Inhibitor Sofosbuvir Appears Safe and Effective for HIV/HCV Coinfected People
September 13

Increased Dietary Fructose Linked to Elevated Uric Acid Levels and Lower Liver Energy Stores
September 13

Ordeal of hepatitis C treatment worth it
September 12

Challenges remain in reaching 100% cure rate in HCV
September 12

Hepatitis C fight - 'watershed moment'
September 12

'Excellent' Survival Seen for Liver Transplant From Live Donor
September 12

Hepatitis C outbreak: Man gets 30 years for infecting patients
September 11

Warning over sirolimus in HCV-positive liver transplantation
September 11

Black Women With HIV and Hep C Less Likely to Die of Liver-Related Disease
September 10

Hepatitis epidemic must be tackled to stop liver cancer cases doubling
September 10

Time to lift hepatitis C stigma
September 10

Holyoke's arrival at needle exchange a rough road despite doctors, other specialists trumpeting its effectiveness
September 9

Impact of ribavirin on response in HIV patients with acute/early HCV
September 9

Increase of Hepatitis seen in the Four States
September 6

Survival "Excellent" Following Living Donor Liver Transplantation for Acute Liver Failure
September 6

Love your liver
September 5

Chronic hepatitis C virus infection increases risk of death from both liver disease and non-liver-related causes
September 5

Prison nurse tied to hepatitis C exposure at Buckeye facility
September 5

Arizona inmates possibly exposed to Hepatitis C
September 4

N.H. hospital resists turning over patient records in Hep C case
September 4

Upcoming FREE NeedyMeds Webinars in September
September 4

HSE's national strategy for hepatitis C to be published
September 3

Hepatitis C outbreak prompts call for drug testing of health care workers
September 2

Triple Infection with HBV Promotes HCV Clearance in People with HIV
September 2

Early treatment could clear Hepatitis C
September 1

Pledge Today To Educate Yourself and Others About Hepatitis C
September 1

Antibody prevents hepatitis C in animal model
August 30

SLU Liver Center is at forefront of new hepatitis C treatments
August 30

Theatre to raise awareness of Hepatitis C
August 29

Achillion Deal Looming as Hepatitis Drugs Fail: Real M&A
August 29

Why Boomers Should Get Tested FactSheet from the CDC
August 28

Vt. baby boomers urged to test for hepatitis C
August 27

Idenix Pharma (IDIX) Says Clinical Hold Placed on IDX19368 by FDA
August 27

Hepatitis C-The "Diabetes-Curious" and Self Inkers/Piercers at Risk
August 26

Former gallery owner fights hepatitis C in Sacramento amid calls for widespread testing
August 26

NH hospital workers urged to get tested following hepatitis C outbreak blamed on lab worker
August 25

Bristol-Myers Squibb Discontinues Development of BMS-986094, an Investigational NS5B Nucleotide for the Treatment of Hepatitis C
August 23

All Nelson area boomers encouraged to test for hepatitis C
August 23

Kansas: Third Hays patient tests positive for Hep C
August 23

"Pharma Greed Kills!": AIDS Activists Take On Hepatitis C
August 23

Australia: PBS decision on Hepatitis C drugs looms
August 23

Response to HCV Therapy Lowers Non-Liver HIV Progression, Death
August 23

Tattoo Inks Pose Health Risks
August 23

More than 60 test positive for hepatitis, but state finds no link to Dean Clinic incident
August 22

CDC Urges Molecular Testing as Follow Up for Positive HCV Antibody Test Result
August 22

The Register editorial: Hepatitis C shows value of health law
August 21

FDA: Reumofan Products Pose Risk to Consumers
August 21

Hepatitis C test for baby boomers saves lives
August 21

Maui AIDS Foundation Helps with New Hep C Recommendations
August 21

Testing the limits
August 20

Infections Among Homeless Could Fuel Wider Epidemics, Study Suggests
August 20

Pakistani son gives new life to mother on his birthday
August 19

Who's to blame in hepatitis case?
August 19

What Hepatitis C Tells Us About Drug Use And Addiction
August 18

Recording Hepatitis C: A Patient's Treatment Journal
August 17

Molecular and protein markers discovered for liver transplant failure from hepatitis C
August 16

Is The Hep C Drug Pipeline Beginning To Crack?
August 16

Idenix hepatitis C drug (IDX184) put on partial hold
August 16

The National Viral Hepatitis Roundtable Welcomes CDC's New Hepatitis C Screening Guidelines
August 16

CDC says: "Born 1945 - 1965? Get Tested for HCV
August 16

Exeter Hospital Hepatitis C Victim Toll Rises
August 15

HCV Type and IL28B Gene Affect Risk of Death in HCV/HIV-Positive
August 15

Laurier students face slight risk of Hep B,C, HIV after class test
August 15

Kansas Updates Potential Hepatitis C Exposures at Hays Medical Center Information
August 14

Major Breakthrough in Hepatitis C Vaccine Development
August 14

Piercing plan for jailbirds incites fury
August 13

New Approach to Treat Acute Liver Failure
August 13

Test all baby boomers to detect hepatitis C, a slow, silent killer (Canada)
August 10

Idenix To Forge Ahead On HCV Combo After Novartis' Departure
August 10

Height, Weight and BMI Changes Seen in Children Treated with Peginterferon Alpha for Hepatitis C
August 9

Hepatitis A Vaccination in Children under Two Remains Effective for Ten Years
August 9

A New Mexico experiment aims to fix the doctor shortage – no new doctors required
August 9

Hepatitis C panel looks at drug-testing
August 9

Achillion Announces Positive SVR4 Results From Phase 2 Study of Sovaprevir (Formerly ACH-1625) and Advancement of ACH-3102
August 7

Exeter Hepatitis C Victim Toll Rises: 31
August 7

Living in the shadow of hep C
August 7

St. John Hospital and Medical Center in Detroit Issues Testing Warning
August 7

Three health care staffing firms face reviews after hepatitis outbreak
August 6

Temple offers hep C testing
August 6

Locations of hepatitis C testing clinics announced
August 6

Stricter body-piercing law takes aim at teenagers
August 6

Thousands to be tested for hepatitis C in New Hampshire
August 3

Free HIV, HCV Testing, Maui
August 3

Triple Therapy Workbooks for Patients Taking Boceprevir or Telaprevir
August 3

Bristol-Myers Squibb Suspends Administration of Study Drug in Clinical Trial of Investigational NS5B Nucleotide for the Treatment of Hepatitis C - BMS-986094 (formerly known as INX-189)
August 2

Las Vegas Hepatitis C Outbreak Claims First Victim
August 1

10th Patient Treated in Extract-1 Study - Analyst Blog
August 1

Saint Luke's to offer free hepatitis C screenings
August 1

Researchers pinpoint peptide that blocks hepatitis C virus entry
August 1

Liver transplant patients who taper off or do not take corticosteroids after transplantation have better quality of life
August 1

FDA Hepatitis Update - Victrelis (boceprevir) label updated for drug-drug interactions
August 1

Obese Donors Increase Risk of Death for Pediatric Liver Transplant Recipients
August 1

Drug users fuel rise in number of Blackburn and Darwen Hepatitis C cases
July 31

The good, the bad and chronic hepatitis
July 31

Vertex Announces Positive Results from Viral Kinetic Study of the Nucleotide Analogue ALS-2200 in People with Hepatitis C
July 30

4 Michigan Facilities Linked to Hepatitis C Investigation
July 30

In Memoriam: John Plater
July 30

Presidential Proclamation -- World Hepatitis Day, 2012
July 30

Foreign media disclose hepatitis numbers on World Hepatitis Day 2012
July 30

Canceled Hepatitis C Tests Flame 'Serial Infector' Fears
July 29

10 to 12 million Pakistanis infected with hepatitis B and C
July 29

Event highlights hepatitis dangers
July 29

Washington Call for Access to HCV Diagnostics, Treatment and Care for All!
July 29

Finland: 1,000 cases of hepatitis-C diagnosed annually
July 28

World Hepatitis Day, 28 July 2012
July 28

OraSure Technologies Supports Rapid HCV Testing Initiatives for World Hepatitis Day
July 27

Pennsylvania hospitals to conduct hepatitis C testing
July 26

Hepatitis C suspect tied to Phoenix hospitals
July 26

Decompensated liver disease more frequent in HIV/HCV co-infected people
July 26

Boomers beware: Hepatitis a silent pandemic in Mendocino County
July 25

Rising numbers of hepatitis C patients treated for liver disease
July 25

Ligand Partner GlaxoSmithKline Announces Priority Review for Supplemental New Drug Application for Promacta(R) for the Treatment of Thrombocytopenia in Adult Patients with Chronic Hepatitis C Infection
July 25

IDX719 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection
July 25

World Hepatitis Alliance Welcomes New Global Framework Aimed at Saving the Lives of Millions Living With Hepatitis
July 24

Official: 6,000 more people to be tested for hepatitis C
July 24

CDC: Hepatitis C suspect Kwiatkowski worked in eight states
July 24

NIH Scientists Identify Likely Predictors of Hepatitis C Severity
July 23

Michigan Among Seven States Wrapped Up in Hepatitis C Probe
July 23

Many Canadians can now be cured of hepatitis C but more trained nurses and doctors are needed
July 23

Vibrio Warning: Europe
July 22

Shirked duty alleged in hep C nightmare
July 22

Kansas hospital warns patients about hepatitis C
July 21

6 other states check for hepatitis
July 21

Canadian HCV management guidelines released
July 21

Hospital worker charged in NH hepatitis C outbreak
July 19

Hepatitis C may increase deaths from both liver-related and other diseases
July 18

Milk Thistle, Taken by Many People for Liver Disease, Ineffective as Treatment for Hepatitis C, Study Suggests
July 17

Vitamin B12 May Significantly Enhance Standard Hepatitis C Treatment
July 17

Insulin Resistance Linked to Liver Disease Progression in HIV/HCV Coinfected Patients
July 17

N.H. hospital to offer new treatment for hepatitis C victims
July 17

Woes of a fatty liver
July 16

FDA Approves First Medication to Reduce HIV Risk
July 16

8,000 patients advised to get HIV, Hepatitis tests after dentist caught reusing needles & syringes
July 15

A stealthy killer, hepatitis C needs wider screening
July 15

Hepatitis C Rates Rise Among Johnson County Young Adults
July 13

Loyola Establishes New Division of Hepatology
July 13

Colo. officials: Dentist reused syringes, needles
July 13

Majority of people with HCV infection may be unaware of condition
July 13

Deschutes County needle exchange program running out of money, needles
July 12

Tapestry Health Begins Needle Exchange Program in Holyoke
July 12

"Ask Me about Hepatitis C" Palm Card – Now Available
July 12

Current and Former Smokers at Risk for Recurrent Hepatitis Post-Liver Transplantation
July 12

Springfield-Greene County Health Dept. Begins Hepatitis C Testing
July 11

Alcoholic hepatitis linked to hepatitis C risk
July 10

HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors
July 10

Volunteer for NIAID Hepatitis C Clinical Research Studies
July 10

Liver Stiffness Predicts Liver Failure, Cancer and Mortality in Cirrhotic Patients Coinfected with HIV/AIDS and HCV
July 10

Levels of Hepatitis C Virus Higher Among African Americans and Males
July 10

Bulgaria Launches Development of National Hepatitis Plan
July 9

Biolex to liquidate after burning $190M on hep C drug
July 9

Hepatitis C treatment offers new hope
July 9

Local clinics offer rapid results for hepatitis C
July 9

Debate over Abbotsford's needle exchange ban
July 7

Antibody Gets High Marks in Small Hepatocellular Carcinoma Trial
July 7

Hepatitis C outbreak at Exeter Hospital in N.H. grows to 27 cases, lawsuits follow
July 5

MedMira Wins $4.2 million U.S. Army Contract to Commercialize Rapid Triple Test
July 4

3D-printed sugar network to help grow artificial liver
July 3

Let's get the facts straight on hepatitis C
July 3

Idenix: New HCV Drug Could Be A Blockbuster
July 3

NH hepatitis C outbreak grows to 27
July 2

ESTIP urges Egyptian patients and liver experts to avoid new unproven Hepatitis C treatments
July 1

New law could affect victims of hepatitis C
June 29

EASL-AASLD Special Conference on Therapy of Hepatitis C: Clinical application and drug development
June 29

Medivir announces an interferon-free phase II combination trial with TMC435 and daclatasvir to commence shortly
June 29

Hepatitis C patients petition for life-saving drug combination
June 28

Supreme Court upholds healthcare law in Obama triumph
June 28

Hepatitis C doctor talks about positive outcomes
June 27

Exeter hepatitis C infections rise to 21
June 27

Hepatitis C doctor talks about positive outcomes
June 27

New National Hepatitis C Referral Resource Maps
June 26

Presidio Pharmaceuticals Successfully Completes Phase 1 Proof-of-Concept for PPI-668, its Potent HCV NS5A Inhibitor, in Hepatitis C Patients with Genotype-1 Infection
June 26

Clipboard: The case for speaking out on HCV
June 25

RiverStone Health offers free HIV and Hepatitis C testing Wednesday, July 27
June 25

Hepatitis: UCSF and San Francisco at Ground Zero
June 23

Senate Passes Bill To Make NJ Needle Exchange Program Permanent
June 22

Hepatitis C support group sharing insights and battling stigmas
June 22

New Legislation Proposed After Hep C Outbreak
June 21

Man exposed to hepatitis C at hospital 'dumbfounded'
June 21

Idenix Announces Positive Clinical Data for HCV Drug Candidates IDX184 and IDX719
June 20

Study May Offer Support for DPP HCV Test
June 20

FBI Joins Criminal Probe of Hep C Outbreak
June 19

Boomers' hep C tests may torpedo insurance chances, experts say
June 19

HCV suppression reduces liver damage
June 19

HIV/hepatitis C co-infection increases risk of hip fracture
June 19

Arthritis therapy tied to liver injury cases
June 18

Scripps Research Scientists Show Lack of Single Protein Results in Persistent Viral Infection
June 17

Hepatitis C outbreaks elsewhere similar to NH's
June 17

More than 2 dozen blood samples botched in hep C probe
June 16

New hope for rising tide of boomers with hepatitis C
June 15

CytoPharm and Amarillo Biosciences Announce Positive HCV Study Results: Oral Interferon Found to Reverse Thrombocytopenia; Reduced Relapse Rate Seen in Patients with Mild Fibrosis
June 15

Drug diversion suspected in NH hepatitis C cases
June 13

Doctors in Europe and the US disagree over the pace of liver fibrosis in men co-infected with HIV and hepatitis C
June 13

1-800-GET-THIN clinics put patients at risk, lawsuit alleges
June 13

Former state Sen. Burt Cohen encourages Baby Boomers get tested for hep C
June 12

Rapid testing a breakthrough in fight against hepatitis C
June 12

More than 27 percent of L.A. homeless adults have hepatitis C, and nearly half don't know it
June 11

THE DUEL: Abbotsford misses mark in passing controversial bylaw
June 11

One-use blood-test device was used with about 80 teens
June 10

Exeter Hospital Hepatitis C Victim Total Rises – Again
June 9

Bill To Expand Needle Exchange Pilot Program Advances
June 7

Successful Pregnancies Possible for Women Following Liver Transplantation
June 7

Exeter Hospital Hepatitis C Outbreak Gets Worse
June 6

Comedian Mike MacDonald Puts Spotlight On Bigger Killer Than HIV
June 6

St. Michael's Opens Center Dedicated to Treatment of Liver Disease
June 5

Kadmon Launches 600 mg/day Ribasphere® RibaPak® to Provide Added Dosing Control for Triple Therapy Treatment of Chronic Hepatitis C
June 5

Exeter Hospital employee among known hepatitis C patients
June 5

Transplant Fundraiser for Andrea Johnson
June 5

Safe in Common to Exhibit at APIC Annual Educational Conference
June 4

N.H. among few with no mandate to report hepatitis C
June 3

Quality of Life Undiminished by Telaprevir in Chronic Hepatitis C
June 2

Inmates remain at risk for HIV and HCV after release from prison
June 2

More hep C cases but no needle decision
May 31

Exeter Hospital: 4 diagnosed with hepatitis C
May 31

FDA says Vertex promotional material overstates benefits of hepatitis C drug
May 31

Curative Hep C Treatment Benefits Non-Liver Health and Survival in HIV
May 31

Boise Bands to Stand and Deliver Against Hep C Wednesday, June 6, at Neurolux
May 30

Top 5 Diseases That Are Misdiagnosed In African Americans
May 30

Addressing Viral Hepatitis at the Department of Veterans Affairs
May 30

GSK seeks to expand low platelet drug Promacta to hepatitis C patients
May 30

Clean needles provided to reduce disease in drug users
May 29

Get in fight early to beat sneaky hepatitis C virus
May 28
 

Webinar Announcement: CDC Overview of HCV Screening Guidelines
May 24
 

HealthWatch: Seale, Alabama man says his hepatitis C is gone; credits research group
May 23
 

U.S. Liver Transplants Declining
May 23
 

Hep C coming back to haunt baby boomers: An interview with Lucinda K. Porter, RN
May 22
 

Experts Discuss DAAs for Difficult-To-Treat Hep C Patients
May 22
 

Achillion Announces Additional Proof-of-Concept Data With ACH-2684 for the Treatment of Hepatitis C
May 21
 

Bay Area health advocates and doctors welcome recommendations
May 21
 

Addict doctor 'spread hep C'
May 21
 

CDC Announces First Ever National Hepatitis Testing Day and Proposes that All Baby Boomers Be Tested Once for Hepatitis C
May 18
 

Orange County: Free Hepatitis Testing and Vaccines Friday and Saturday
May 18
 

Hepatitis C increased in rural Wisconsin
May 18
 

CDC Releases Birth Cohort HCV Screening Guidelines and Funding Announcement
May 18
 

Telemedicine Program Improving HCV Care for Rural Veterans
May 18

Patient group rouses Oakland against the 'Silent Killer'
May 18
 

OraSure Technologies Announces Rapid HCV Testing Initiatives for First National Hepatitis Testing Day
May 18
 

Mayor Lee and U.S. Centers for Disease Control (CDC) Kick Off Historic 1st National Hepatitis Testing Day in San Francisco
May 18

All baby boomers should get hepatitis C test -CDC
May 18
 

Mansfield Ohio Health Department Offering Hepatitis C Screening
May 17
 

Hawai'i: State offering free Hepatitis B & C testing
May 17
 

The struggle against Hepatitis C
May 17
 

Hep-C increasingly affecting county's young people
May 17
 

Incivek Rash Reports: What HIV/Hepatitis C-Coinfected People Need to Know
May 17

Class action over hepatitis C scandal
May 16
 

Ribavirin Helps Early Hepatitis C Treatment in People with HIV
May 16
 

Medical Edge: Liver Treatment—Magnetic Resonance Elastography, or MRE
May 15
 

Ottawa comedian's kidneys, liver shut down
May 15
 

Gastroenterology Special Issue Focuses on New Directions of Viral Hepatitis Care and Research
May 15

ACH-3102 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C
May 15

Syringe exchange programs reduce disease and save taxpayer dollars
May 14

 One Racing Family's Journey to Create Hepatitis C Awareness & End it Once & For All. Comedian Susan Dale Recently Shared Her Families Story at Business Event in Tulsa, OK
May 14

 OKC Woman Stuck by Syringe Inside Peat Moss
May 13

Thomas Jefferson University Hospital Creates Comprehensive Hepatitis C Center
May 11

Mayo Clinic technician pleads guilty to spreading hepatitis C
May 11

Charges stand in hep C case against former doctor
May 11

Guest Commentary: Baby boomers and hepatitis C in Colorado
May 11

B.C. foster mom has Hepatitis C lawsuit dismissed
May 10

Newsmaker: Paul Plaisir, hepatology nurse, discusses Hep C
May 10

Achillion Advances Second Generation Pan-Genotypic NS5A Inhibitor, ACH-3102, Into Clinical Development
May 9

U.S. may speed approval of 'breakthrough' drugs
May 9

Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy
May 8

  EASL 2012 Promising Findings for Therapeutic Hepatitis C Vaccine TG4040
May 8

Declaring war on Hepatitis-C: Free screenings Libby Montana
May 8

Hepatitis C warning as home tattoo kit sales rise
May 8

Intensive Follow-up Reduces Mortality from Hepatocellular Cancer
May 7

Fraser Health urges Abbotsford to get rid of anti harm-reduction bylaw
May 7

Bristol-Myers Missing Hep C Data Raises Red Flags, May Boost Gilead, Idenix
May 7

Liver transplants in HIV-HCV co-infection—results from a U.S. study
May 7

Co-infection with hepatitis C increases mortality risk by 50% for patients with AIDS
May 6

As a Tribute to His Father, Secada Wages War on Hepatitis C
May 5

Pitt dental school accused of negligence, using dirty equipment
May 5

B.C.'s medical officer raises question over blood-sample bill
May 5

Free Hepatitis Testing Day Statewide Hawai'i – Friday, May 18, 2012
May 5

Board reprimands nurse who potentially exposed patients to hepatitis, HIV
May 5

SPECIAL REPORT: Teens & Tats ... Paying the price
May 4

Medical marijuana backers have six weeks to collect signatures for ballot question
May 4

Being an organ donor
May 4

Second Annual Zebrowski Walk On May 12
May 4

Opening a New Chapter in HCV: Focus on Successful Outcomes with HCV Protease Inhibitor Therapy A Virtual Education Summit
May 3

Opening a New Chapter in HCV: Focus on Successful Outcomes with HCV Protease Inhibitor Therapy A Virtual Education Summit
May 3

Boy undergoes HIV, hepatitis treatment after finding syringe at Oakland playground
May 3

Hepatitis C infections grow at an alarming rate
May 3

Hepatitis C Cases on the Rise in Northern Kentucky
May 2

Prison puzzle: Treating hepatitis C
May 2

Interferon linked with increased risk of depression in HCV patients
May 2

Hepatitis C a latent legacy of baby boomers' youth
May 2

Facebook to Promote Organ Donation; May Benefit People With Hep C or HIV
May 1

Hepatitis Awareness Month at the CDC
May 1

Maybe There Will Be Some Hep C Patients Left
April 28

Ryan White: Back, But Not Without Issues
April 28

U.S.: Do not mix Merck hepatitis pill with HIV drugs
April 26

Patient Survival Not Impacted by Liver Transplants Performed at Night or on Weekends
April 26

NICE has given its final recommendation for two new hepatitis C pills in an expedited review
April 25

Updated Event and Training Workshop Schedules
April 25

Abbotsford drug use trending up, Hep C rates high: Fraser Health report shows
April 24

INCIVEK(TM) (telaprevir) Now Funded for People With Hepatitis C in Quebec and Saskatchewan
April 24

Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
April 24

Family History of Liver Cancer Increases Risk of Developing the Disease
April 24

Fibrosis and Fatty Liver Disease Increase Risk of Early Atherosclerosis
April 24

Achillion Pharma slumps on hepatitis C drug data
April 23

 Mobile hepatitis C screening to be held in four Warwickshire towns
April 23

 Sharing the gift of life: Local couple in need of organ transplant raises organ donor awareness
April 21

 FDA Hepatitis Update - Victrelis (boceprevir) label change reflects drug-drug interaction information with HIV protease inhibitors
April 20

 National Hepatitis Testing Day (May 19) Site Now Live
April 20

 Patient dies during Novartis clinical trial of Alisporivir
April 19

Medivir Announces TMC435 in an Expanded Clinical Collaboration
April 18

National Hispanic Hepatitis Awareness Day 2012 Official Website Launch
April 18

Government tries to have foster parent's Hepatitis C lawsuit tossed out of court
April 17

The Race To Create The Best Antiviral Drugs
April 17

ELPA Coverage of EASL 2012
April 17

Needle exchange program opens doors to city's most vulnerable population
April 16

Inked or infected: Tattooing comes with risks
April 14

Silent epidemic calls out for cure
April 14

Liver Fibrosis Tests Predict Mortality in HIV/HCV Coinfected Women
April 14

Man grateful to be alive after doctors at the U. performed a transplant first
April 12

San Diego City Council Grants $51,000 for Needle Exchange Program
April 12

Taking Your Hepatitis C Triple Therapy
April 12

In Memoriam: Michael Carden 1971-2012
April 12

Cirrhosis and hepatitis C to be discussed at forum
April 11

Issues go unsolved at St. Louis VA medical center
April 11

Drug injection sites urged for Ottawa, Toronto
April 11

Discordance between CD4 cell count and percentage associated with markers of liver disease in HIV/hepatitis C co-infected people
April 10

Man Who Contracted Hepatitis C Sues Dean Health
April 10

Report : Cochran VA hasn't solved dental issues
April 10

$1.1 M for hepatitis C screenings and treatment
April 9

Bristol-Gilead Hep C Drug Data Leaks
April 9

What You Don't Know, You Can Sell
April 9

Staff catch hepatitis C from dirty needles while working at NHS Greater Glasgow & Clyde
April 8

Hepatitis C poses a silent crisis
April 6

Lessons Shared from Transmission of Hepatitis C Infection to Patients
April 6

Hepatitis C infections now twice as likely in HIV+ gay men as in injecting drug users, Swiss study finds
April 6

In hepatitis C: Curing the incurable
April 5

Jon Secada's new single is a love song to his Dad
April 5

Mass. residents, representatives discuss Hepatitis C prevention
April 4

Promising Vaccine Targets On Hepatitis C Virus
April 4

Abbott to Present Positive Phase 2 Results from Multiple Interferon-Free Studies of Combination Regimens for the Treatment of Hepatitis C
April 4

Metformin Helps Some Cancer Patients
April 3

Nurse lobbying for hep C treatment changes
April 2

Tremelimumab Shows Promise in Treatment of Liver Cancer
April 2

Save the Date - HCV Tribal Summit: May 9th and 10th, 2012 Shooting Star Hotel and Casino Mahnomen, MN
April 2

Over 20 Million Individuals Infected with Hepatitis E in Asia and Africa
April 2

Detection and Treatment for Hepatic Encephalopathy Prevents Car Accidents, Reduces Costs
April 2

Increasing Routine Viral Hepatitis Testing
March 30

Hepatitis C Review: Acetaminophen - Tylenol
March 29

Hepatitis C Information and Support Group with Book Signing
March 30

Arizona Supreme Court hears Mesa tattoo case
March 29

HIV, Hepatitis C rapid testing now in D.C.
March 29

Video - Featuring Hepatitis C Advocate Shari Foster
March 28

Antiretroviral rollout provides a model for efforts to expand hepatitis C treatment and care in resource-limited settings
March 28

VICTRELIS™ Now Available for Eligible Patients in British Columbia
March 28

CROI 2012: Two hepatitis C drugs greatly increase HCV cure rates in co-infected people
March 28

Screening for hepatitis C in jail
March 28

Scots hepatitis campaign praised in European study
March 26

Chlamydia, Hepatitis C lead diseases reported by Ross health district
March 26

New manual provides guidance in addressing viral hepatitis in people with substance use disorders
March 26

Cops challenge Tattoo cover up rule
March 26

Tattoo competition to include local artist
March 26

Liver Cancer Patients Less Likely to Die on Wait List than Candidates without Carcinomas
March 22

Liver disease deaths jump 25% in England: study
March 22

Action Alert - Act Now: End Federal Funding Ban on Syringe Exchange Programs
March 21

Top court rules against two diagnostic patents
March 19

Discovery Provides Blueprint for New Drugs That Can Inhibit Hepatitis C Virus
March 19

877-HELP-4-HEP; a Peer Advocacy Success Story
March 19

Needle exchange program is a health care necessity
March 19

CROI: HIV/HCV Coinfection News from CROI 2012 [VIDEO]
March 18

New York City hitting hepatitis C
March 17

Treating HIV During Pregnancy Also Lowers Risk of Transmitting Hep C to Baby
March 17

NICE recommends Incivo for hepatitis C
March 16

BCRX challenges Biota patent, claims its hepatitis C compound was first
March 16

Liver Transplant Program at Methodist Specialty and Transplant Hospital Recognized as Best in the Nation
March 15

Broader screening for hepatitis C would be cost effective, study suggests
March 15

Updated Hepatitis C Evaluation and Treatment Guidelines from Bureau of Prisons
March 14

Okairos announces initiation of Phase I/II clinical trial for potential first-in-class hepatitis C vaccine
March 14

Hepatitis C Infection Increasing Among Adolescents, Young Adults
March 13

Medivir announces new studies in phase III program for TMC435
March 13

Familiarity With Drugs Helps a Group Speak for Users
March 12

New Hep C meds may override watchful waiting for patients with no symptoms
March 11

Wilmington tattoo shop shuttered by Delaware health division
March 10

Court revives suit over NY prison medical care
March 9

Merck's hepatitis C drug wins UK cost endorsement
March 9

Hepatitis C test helps curb Egypt epidemic
March 9

ACTION ALERT: Urge Your Members of Congress to Ensure Our Nation Is Properly Funding Viral Hepatitis Programs
March 8

National Consumer Protection Week and FDA's Fight Against Health Fraud Scam
March 8

Results from Investigational Studies with VICTRELIS™
March 7

HCV vaccine – it’s coming in big steps
March 7

National Day of Action for Syringe Exchange
March 7

*ACTION ALERT* Call your member of Congress today about the CDC Hepatitis C Screening Guidelines!
March 7

Scientists Develop Better Test for Identifying Hepatitis Type
March 6

Data from Phase 2 Study of an INCIVEK® Combination Regimen Showed 74% of People Co-Infected with Hepatitis C and HIV Had Undetectable Hepatitis C Virus 12 Weeks After Treatment Ended (SVR12)
March 6

Prison dispatch: Hepatitis epidemic could become costly
March 6

Patients with hepatitis C virus infection who adhere to their drug regimen are more likely to show long-term benefit
March 6

Tattoo you? Beware the Dangers
March 5

Jerry Davich: Dear boomers, are you positive that you're negative?
March 4

Experts stress Hepatitis C testing, awareness
March 4

Cirrhotic Patients Experience Increased Daytime Sleepiness from Higher Ammonia Levels
March 2

Hypoferremia Predicts Treatment Response to IFN-α
March 2

New Treatment Improvement Protocol (TIP), Addressing Viral Hepatitis in People With Substance Use Disorders
March 1

*ACTION ALERT* Urge Your Members of Congress to Support Viral Hepatitis Funding In Their Appropriations Programmatic Requests
March 1

Cholesterol-Reducing Statins, Other Meds to Be Avoided With Hep C Protease Inhibitors
March 1

Lieutenant Kurt Beach recovering from Hepatitis C after trying to save baby
March 1

Hepatitis C subtype-1b and carriage of IL28B gene associated with improved treatment responses in HIV-co-infected patients
March 1

Vertex Announces 12-Week On-Treatment Data and SVR4 From Phase 2 Study of Interferon-Free (All-Oral) Treatment Regimen of INCIVEK®, VX-222 and Ribavirin in People with Genotype 1 Hepatitis C
February 29

Ultrasound Technology Proves Accurate in Diagnosing Cirrhosis from Recurrent Hepatitis C
February 29

How FDA Ensures the Safety of Blood Products
February 29

Vancouver Island Hep C victim caught in Catch-22
February 29

World Hepatitis Alliance - Newsletter
February 28

Stanford scientists model hepatitis C treatment options
February 28

Point-of-Care HCV iPhone/iPad App from Projects In Knowledge
February 24

Doc: All Should Be Screened For Hepatitis B, C
February 23

HepQuant to Begin Clinical Study of Liver Function Measurement Tests
February 22

Enanta's Hep C drug deal with Novartis worth up to $440M
February 21

Hepatitis C protease inhibitor therapy cost effective in some circumstances
February 21

Hepatitis C deaths up, Boomers most at risk
February 20

Gilead Suffers First Hep C Drug Setback
February 17

Gilead Announces Data for Genotype 1 Null Responder Hepatitis C Patients Enrolled in ELECTRON Study
February 17

Virology Profile Following Treatment With ACH-1625 Discussed in Oral Presentation at 2012 Asian Pacific Liver Conference
February 17

Lack of donor organs and poor access to treatment mean mortality rates for liver disease destined to rise
February 16

Singer Jon Secada Joins Merck and American Liver Foundation's 'Tune In to Hep C' Public Awareness Campaign (Spanish Version–En Español)
February 16

Hepatitis C Community Advisory Board (HCAB) DDI statement
February 16

Alberta researchers develop vaccine to fight hep C
February 15

Hepatitis C on increase in Dunedin
February 15

BioCryst Announces Promising Results from Preclinical Studies of BCX5191 for Hepatitis C
February 15

Bristol-Myers Squibb Completes Acquisition of Inhibitex, Inc.
February 14

New stand on heroin at Footscray addiction clinic
February 13

President's Budget Restores Community Control on Federal Funding for Syringe Exchange
February 13

Professional tattooing in sterile environment not associated with risk of hepatitis C
February 13

Complete early virological response was highly achieved by double filtration plasmapheresis plus IFN-beta induction therapy for HCV-1b patients with relapse or no response after previous IFN therapy
February 13

Saugus family hopes for conclusion in benefits battle
February 12

Illegal tattooing on the rise in Surry County
February 12

Making History: Eliminating Viral Hepatitis Disparities in the African American Community
February 10

Interferon and ribavirin control HCV genotype 6
February 9

VICTRELIS™ (boceprevir) and Ritonavir-Boosted HIV Protease Inhibitors May Indicate Clinically Significant Drug Interactions for Patients Coinfected with Chronic Hepatitis C and HIV
February 8

Amateur tattoos carry hepatitis C risk: CDC
February 7

As death nears, hepatitis C victim to give videotaped deposition in Desai case
February 7

NIH Launches "Clinical Research Trials and You" Website
February 6

BioLineRx In-Licenses Second Oral Hepatitis C Treatment
February 6

Alanine Aminotransferase Levels ID Liver Disease Risk
February 4

Idenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide Inhibitor, IDX184
February 3

Inability to work due to work-related injury alone curbs nurse's claim
February 2

Even in sickness, EMT from West Haven strives to help others
February 2

Coffee Consumption Reduces Fibrosis Risk in those with Fatty Liver Disease
February 2

Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C (HCV) Patients Receiving Hemopurifier® Treatment Protocol
February 1

Hepatitis A vaccination rates vary greatly from state to state
January 31

Cardiopulmonary Exercise Testing May Predict Post-Liver Transplantation Survival
January 31

Cell Permeable Peptide Identified that Inhibits Hepititis C Replication
January 30

Stem cells may shed light on hepatitis, MIT researchers find
January 30

Alcohol Treatment Boosts Hep C Cure Rates Among Drinkers
January 30

Sign the Syringe Exchange Program Ban Position Statement
January 30

Scientists show brain vulnerable to Hepatitis C virus
January 18

Israelis find vitamin D helps against liver diseases
January 17

Kidney failure risk higher for liver transplant patients following allocation policy change
January 16

Researchers Discover Means for Blocking Hepatitis C Infection
January 16

FREE HIV and Hepatitis C testing coming to Guerneville Jan 18, 2012
January 15

CDC Warns Against Sharing Insulin Pens
January 14

Hep C threat to health services
January 13

Merck Hepatitis C Drug May ‘Anchor' Future Worldwide Regimen
January 10

Alarming Incidence of Hepatitis C Virus Re-Infection After Treatment of Sexually Acquired Acute Hepatitis C Virus Infection in HIV-Infected MSM
January 10

New Target and FDA-Approved Cholesterol-Lowering Drug Identified for HCV Therapy
January 10

No link yet between hepatitis B, C cases and Ottawa clinic
January 10

New Fibrosis Classification Improves Accuracy of Diagnosis in Hepatitis C
January 10

High Rates of Disability and Health Care Use for Older American with Cirrhosis
January 10

Achillion Reports Clinical Data on Portfolio of Protease Inhibitors
January 9

Presidio Pharmaceuticals Reports Progress with Hepatitis C Antiviral Programs
January 9

Idenix Reports Advancement of HCV Development Pipeline
January 9

Idenix Reports Positive Interim Data for HCV Nucleotide Inhibitor, IDX184
January 9

Bristol-Myers Squibb to Acquire Inhibitex
January 8

Researchers Identify Liver Cancer Risk Factors
January 7

HCV Antivirals Cost-Effective for Injecting Drug Users
January 7

ACH-1625 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C
January 4

Therapies Can Extend Life in Infiltrative Liver Cancer
January 4

Experimental hepatitis C vaccine shows early promise
January 4

Experts Issue Early Guide for Hep C Protease Inhibitor Therapy in People Living with HIV
January 3

Can-Fite BioPharma Announces Successful Results of its Phase I/II Liver Cancer Study with its CF102 Drug; the Study Achieved the Primary and Secondary Endpoints
January 3

Hepatitis C virus hijacks liver microRNAs to survive
January 3

Mayo study links hepatitis C to liver cancer
January 3

As part of new program, two St. Luke's patients receive liver transplants
January 1

 

Top News 2011

Free pipes distributed to curb disease
December 31

Participants Needed for Hepatitis C Treatment Study. Reimbursement Available
December 29

Gregg Allman touts importance of hepatitis C testing, reflects on his recovery
December 29

Peregrine Provides Update on HCV Clinical Program
December 29

Incivek and Victrelis Usage as Part of Triple Therapy Hepatitis C Regimen is Emerging as the New Standard of Care for Genotype 1 Patients According to a Newly Released Report by BioTrends Research Group
December 23

Incivo approved in Scotland
December 23

Hepatitis outbreak grows
December 23

Child gets hepatitis C from transplant at Boston hospital
December 22

Drug Users in California to Have Better Access To Clean Needles
December 21

Safe injection site plan is scientifically sound: health official
December 18

Congress to Restore Federal Syringe Exchange Funding Ban as Part of 2012 Spending Package
December 17

Safety (Still) Trumps Acquisitions in Hep C
December 17

Research could solve donor liver shortage
December 16

Outbreak of Hepatitis A on Vancouver Island Hitting Aboriginals Hard
December 16

Pharmasset Halts Studies with PSI-938
December 16

Merck and Roche team up for hepatitis C studies
December 16

Clinical Care Options Launches CCO Hepatology inPractice™, Adding a Third Specialty to its Comprehensive Online Resource
December 16

Pharmasset Announces Intent to Amend QUANTUM Trial
December 16

URGENT ACTION REQUESTED: Syringe Exchange Federal Ban
December 15

Obesity and Diabetes Epidemics Spur Increase in Nonalcoholic Steatohepatitis
December 15

Doctors say they have no duty to lock up sedatives
December 12

Amick: The needle exchange debate
December 12

Federal funding for syringe exchange is under attack!
December 12

Hepatitis C cases drop in P.E.I. since opening of needle exchange
December 12

Patient Advocate Foundation Announces $9.3 Million Donation to their Co-Pay Relief (CPR) Program
December 10

Hepatitis C Medicines Save Lives in Cambodia
December 9

Vertex and Alios BioPharma Begin Clinical Studies of Nucleotide Drug Candidates ALS-2200 and ALS-2158 for the Treatment of Hepatitis C
December 9

Boehringer Ingelheim completes patient entry for Phase III trial programme in Hepatitis C
December 9

HCV Infection May Predict Coronary Artery Disease
December 8

Lipid-modifying enzyme: New target for pan-viral therapeutics
December 7

Biotron brings hope for Hepatitis C sufferers
December 7

Limitations in Liver Cancer Screening Uncovered
December 6

New Jersey Legislators OK needle exchange program
December 6

Achillion Announces Preliminary Phase 1b Proof-of-Concept Data With ACH-2928 NS5A Inhibitor for the Treatment of Hepatitis C
December 5

Too promiscuous to donate an organ? Maybe, CDC says
December 5

In The Spotlight-HCV Advocate and Ms. Lucinda K. Porter, RN.
December 5

Ottawa's crack pipe exchange is working, study finds
December 2

Medivir - TMC435 will be evaluated in a phase II combination study with daclatasvir (BMS 790052) for HCV genotype-1 patients
December 2

Low-Dose IL-2 Induced HCV Vasculitis Remission
December 1

Living in fear of dying
December 1

Transplant Candidates Seek "Best Quality" Livers Despite Having to Remain on Waiting List
December 1

Green Tea Flavonoid May Prevent Reinfection with Hepatitis C Virus Following Liver Transplantation
December 1

Studies of Patients with Cirrhosis Uncover Limitations in Liver Cancer Screening
December 1

FDA Hepatitis Update - CLIA waiver expands availability of rapid blood test for antibodies to the hepatitis C Virus (HCV)
November 29

Hepatitis common at Washington Penitentiary
November 29

Drug-resistant Hepatitis C
November 29

Bread of Healing Clinic connects patients with needed drugs, care
November 27

The redlining of harm reduction programs
November 24

'May I Be Frank': A Life-Changing Documentary
November 23

Hepatitis Screening Offered With Routine Colonoscopy Accepted by 75%
November 23

VICTRELIS™ Now Available for Eligible Patients in Ontario
November 22

University launches iphone app for hepatitis treatment
November 22

Gilead to Buy Pharmasset for $11 Billion to Win in Hepatitis
November 21

4 Hep C cases found after Ottawa clinic scare
November 16

UPMC organ transplant program placed on probation
November 15

Liver Cancer: Increasing Incidence, But Greater Therapeutic Options
November 12

CDC Poised to Advise Screening Baby Boomers for HCV
November 10

Adherence to Hepatitis C Treatment Interventions: A Comparative Effectiveness Review
November 10

Incivek, Victrelis Working Well in HIV/HCV Coinfection Studies
November 10

New FDA Website: Needles and Other Sharps (Safe Disposal Outside of Health Care Settings)
November 9

The Crisis of Hepatitis C and Intravenous Drug Use
November 9

Patients With Chronic Viral Hepatitis Should Be Tested for Vitamin D
November 9

A Note on Hepatitis C Treatment and Medigap
November 9

Liver donors have complaints years later: study
November 5

New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1
November 4

New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1
November 4

Inhibitex skyrockets on promising oral Hep C drug program
November 4

Impact of sirolimus on HCV progression in liver transplant recipients
November 4

Persistence of very low levels of virus increase risk of relapse after hepatitis C therapy
November 4

Hepatitis C transmission via injecting drug use: look beyond needles and syringes
November 4

Birth cohort screening for hepatitis C is cost effective, could save thousands of lives each year
November 4

Vertex Announces Recipients of Special Grants Initiative to Support People with Hepatitis C
November 4

Putting an end to viral hepatitis: America's silent killer
November 3

U.S. Assistant Secretary for Health Speaks On Important Bay Area Efforts to Eradicate Viral Hepatitis
November 3

Medivir Announces Final Results from TMC435 Phase IIb ASPIRE (C206) Study
November 2

Pharmasset Announces the Initiation of an Interferon-Free Phase 3 Program with PSI-7977 for HCV
November 1

Notes from the Field: Risk Factors for Hepatitis C Virus Infections Among Young Adults --- Massachusetts, 2010
October 29

Vertex Starts Global Phase 3b Study to Evaluate the Potential for People with Hepatitis C to Achieve a Viral Cure (SVR) with a Total Treatment Duration of 12 Weeks of INCIVEK™ Combination Therapy
October 24

Boehringer Ingelheim announces new data from hepatitis C virus portfolio
October 22

European studies on risks of hepatocellular carcinoma
October 21

Abbott says hepatitis C combo may be a blockbuster
October 21

Interim Phase IIb Data for Merck's VICTRELIS(TM) (boceprevir) in Patients Coinfected with Chronic Hepatitis C and HIV-1
October 20

New European HIV treatment guidelines expand treatment recommendations
October 18

SF leaders unite to call on mayoral candidates to end liver cancer and hepatitis
October 18

People on methadone can succeed on hepatitis C treatment
October 18

Inovio Pharmaceuticals and VGX International to Advance Therapeutic Hepatitis C and Hepatitis B Synthetic Vaccines into Clinical Studies
October 17

Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market
October 17

Roche Buys HCV Therapeutics Firm Anadys for $230M in Cash
October 17

Largest Ever Genetic Study of Liver Function Could Point the Way to New Treatments
October 16

6,800 may be exposed to HIV, hepatitis infection at Ottawa clinic
October 16

Gene variant that helps hepatitis C treatment may hinder HIV treatment
October 15

Yale research reveals novel aspects of virus-fighting protein
October 14

From Needle Stick to Cure for Hepatitis
October 14

UC San Diego School of Medicine Launches Hepatitis C Clinical Trials
October 13

Anadys Announces Positive 12-Week Data for Setrobuvir in Phase 2b Hepatitis C Study
October 13

Project ECHO brings faraway specialists close to home
October 12

Americans Discard 7.8 Billion Needles Every Year
October 12

AFP Level Predicts Mortality in Hepatitis C-Related Liver Cancer
October 12

Transgene Announces Important Update on its HCVac Study with its Therapeutic Vaccine TG4040 in Chronic Hepatitis C
October 12

Gov. Jerry Brown signs bills expanding drug user access to syringes
October 11

Scripps Research receives NIH grant to determine how HCV induces liver cancer
October 11

Engineering Hope: Curing Hepatitis C
October 11

Inovio, VGX to develop vaccines for Hepatitis B and Hepatitis C
October 11

INCIVEK™ (telaprevir) Now Available in Canada for People with Hepatitis C
October 11

INCIVO® (telaprevir), a new treatment for genotype-1 chronic hepatitis C launched today
October 10

BIT225 Hepatitis C Phase 2A Trial Positive Results
October 10

Pharmasset Announces Further Expansion of ELECTRON Trial in Hepatitis C
October 10

Deferasirox Can Improve Liver Fibrosis, Necroinflammation
October 1

'Micro'-Chemo and Cancer Pill Combo Tested in Liver Cancer Patients
October 1

Mallory-Denk Bodies on Biopsy Predict Fibrosis Progression in HCV
October 1

Hepatitis C in the U.S. May Be Underestimated by Over a Million
September 30

Safe drug-injection site can stay: Supreme Court of Canada
September 30

Hepatitis C patients likely to falter in adherence to treatment regimen over time, Penn study shows
September 30

Alcohol impairs the body's ability to fight off viral infection
September 30

Consider Hepatitis C Infection in Some Arthritis Patients
September 29

Updated Hepatitis C Practice Guidelines Now Available from AASLD C
September 28

High-Risk Donor Livers Used with Greater Frequency in Transplantations C
September 28

Liver Cancer Incidence Lower in Nonalcoholic Fatty Liver Disease Patients than in those with Hepatitis C
September 27

Living Donor Liver Transplantation Improves Survival Over Deceased Donor Transplants
September 27

Peregrine Completes Patient Enrollment in Randomized Phase II HCV Trial for Bavituximab
September 26

'Step Up To The Plate' Against Hepatitis C
September 24

European Medicines Agency Recommends Restricting Use of Dronedarone
September 22

CDC: New proposed guidelines for organ transplantation
September 22

Pittsburgh Couple Sue Hospital Over Hepatitis C-Infected Kidney Transplant
September 21

SomaGenics' sshRNA Technology Demonstrates Efficacy of RNAi Against Hepatitis C Virus
September 21

Vertex, J&J hepatitis C drug (Incivo) gets EU nod
September 20

Danger Signal Limits Hepatitis C Infection
September 19

How our liver kills 'killer cells'
September 19

Shark-Derived Drug May Treat Viruses
September 19

Rapid anti-HCV tests can provide sensitive and specific anti-HCV results for high-risk patients
September 19

Inhibitex Commences Dosing of Phase 2 Clinical Trial of INX-189 in HCV Infected Genotype 2/3 Patients
September 19

Sanford Guide Introduces New Hepatitis Guide
September 18

Coffee Helps Minimize Hepatitis C Treatment Side Effects
September 16

Early Data on BMS-790052 HCV NS5A Inhibitor Published
September 16

Hepatitis B and C Coinfection among HIV Positive People in the U.S.
September 16

High viral cure rate achieved with a 24-week INCIVEK combination regimen
September 14

Genotyping HCV Patients for HLA-C and IL28B Improves Ability to Predict Treatment Response
September 14

Needle exchange program in the works for county's IV-drug users
September 13

Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and PSI-938 for All HCV Genotypes
September 13

Drug users help boost hope for hepatitis C vaccine
September 12

New Treatment Options Are On The Horizon For People Co-Infected With HIV And Hepatitis C Virus
September 7

Pharmasset Announces 91% SVR12 From the PROTON Trial in Subjects With Hepatitis C Genotype 1
September 7

Gilead Amends Study Design for Ongoing Hepatitis C Clinical Trials That Include GS 9190, Pegylated Interferon and Ribavirin, and Another Direct-Acting Antiviral Agent
September 5

New Hep C drug priced out of reach of most patients
September 1

Clinic may have exposed patients to HIV, hepatitis: How to stay safe
September 1

Poor healthcare in Victoria's jails a "major threat"
September 1

Changes to Distribution of Livers for Transplant Proposed
August 31

Bruce DeVenne Dies of Cancer
August 31

Ignored Virus Can Cause Liver Cancer, Study Suggests; Should We Be Screening Blood for Hepatitis G?
August 24

FDA Approves Pegasys/Copegus for Pediatric HCV Infection
August 24

Pharmasset receives fast track designation for Hep C drug PSI-938
August 24

HIV Linked to False Negative Hep C Results Using Some Rapid Assays
August 23

Dual Hepatitis B, C Infection Ups Lifetime HCC Risk
August 23

Patient Advocate Foundation Announces Additional Support for Patient Co-Pay Relief Program Serving Breast Cancer, Colon Cancer, Hepatitis C Patients
August 22

Vertex Pharma Says Health Canada Okays INCIVEK For People With Hepatitis C
August 22

Blacks With HCV May Benefit Most From Boceprevir and Telaprevir
August 22

Radioembolization Improves Chance of Survival for Liver Cancer Patients
August 22

Saffron Shows Promise in Preventing Liver Cancer
August 22

Step up to the plate against Hepatitis C
August 21

Use of New HCV Protease Inhibitors 'Not That Simple
August 16

Scotland faces Hep C timebomb with 30 new cases every week
August 10

In Memoriam: Emmet B. Keeffe, MD
August 8

New Book on Hepatitis C: James with a Silent C
August 8

Investigators Identify Inactivating Mutations in Tumor Suppressor Gene ARID2 in HCV-associated HCC Patients
August 5

Victrelis (boceprevir) Approved in Canada
August 3

Chronic Hepatitis C Genotype 1 Drug, Victrelis (Boceprevir) Launched In UK Today
August 3

Counseling, Drug Treatment Can Increase Hep C Treatment Eligibility
August 3

Vancouver Coastal Health tries new approach to reduce spread of hepatitis C
August 2

Going to the Cubs game? Get tested too
August 2

Chronic hepatitis C estimated at 9.2 million individuals in Middle East and North Africa
July 31

United Kingdom: Programs May Curb Hepatitis C in Drug Users
July 30

New vaccine for hepatitis C virus
July 29

National Minority Quality Forum Launches the Hepatitis C Index
July 28

Safe injection sites needed Canada-wide to fight hep B, C
July 28

Hepatitis B and C Prevalent in Injecting Drug Users
July 28

Boceprevir response and resistance differs according to HCV genotype 1 subtype
July 28

Interim Data from Phase 2 Study of Combination Regimen Including VX-222 and INCIVEK™ Suggest Potential to Treat Genotype 1 Hepatitis C in as few as 12 Weeks and No More Than 24 Weeks
July 26

Hepatitis C is transmitted by unprotected sex between HIV-infected men
July 21

Pharmasset Announces Final SVR Data from PROTON trial with PSI-7977 in Subjects Infected with Hepatitis C Infection Genotype 2 or 3
July 20

Walgreens Specialty Pharmacy Drives Adherence for Hepatitis C Patients Through Therapy Management Program
July 19

Transplant Error Finds More at Fault
July 19

Crack Pipes 'Not Authorized' in Kits
July 19

Health Officials Work to Curb Mercer Co. Hepatitis
July 18

VICTRELIS(TM) (boceprevir), First-in-Class Oral Hepatitis C Virus Protease Inhibitor, Approved in the European Union for Treatment of Chronic Hepatitis C
July 18

Tainted-Blood Victims Not Told about Compensation Availability
July 17

Vaccination Rates Up for Those With Liver Disease, Diabetes
July 15

UPMC Gets Approval to Restart Living Donor Transplant Programs
July 15

Local Drug Programs Aim to Contain Spread of Infections
July 14

Achillion Announces Initiation of Phase 1 Trial of ACH-2928 for the Treatment of Hepatitis C
July 12

Health 411: Medicare Guidance Is Here
July 11

NIOSH Launches New STOP STICKS Campaign Website
July 11

Medicaid Improves Health and Budgets of Poor
July 7

Pharmasset Enters into a Clinical Collaboration Agreement with Tibotec Pharmaceuticals for a Combination Study in Patients Chronically Infected with Hepatitis C
July 6

TMC435 Has Received Fast Track Designation from the FDA and TMC435 Will Be Studied in Combination withPharmasset's PSI-7977 for HCV Genotype-1
July 6

Hepatitis C Cases in Region on the Rise
July 5

Living Donor Liver Transplantation from a Donor Previously Treated with Interferon for Hepatitis C Virus: A Case Report
July 3

Safe Crack Kits Face Challenges in Use: Study
July 3

Genetic Variant Linked to Development of Liver Cancer in Hepatitis C Virus Carriers
July 3

Innovative Vaccines with Nanotechnology
July 1

Programs May Curb Hepatitis C in Drug Users
June 28

Affordable Care Act Delivers Cheaper Prescription Drugs to Nearly 500,000 People
June 28

Gene Variant Increases Fatty Liver Risk and Fibrosis Progression
June 28

Hepatitis C on the Rise in Mercer County
June 27

Liver Fibrosis Tied to Hep C-Related Vasculitis Prognosis
June 24

FDA Urges Caution on Amgen, J&J Anemia Drugss
June 24

TMC649128 enters Phase Ib Trial in Patients Chronically Infected with Genotype-1 Hepatitis C Virus
June 22

Achillion Initiates 12-Week Dosing in Phase 2 Trial of ACH-1625 for the Treatment of Chronic Hepatitis C
June 22

Angioplasty May Be Feasible for Liver Transplantation Candidates with Heart Disease
June 22

NAT Screening May Lower Undetected Hep C in Donors
June 21

Hep A Immune Response Mystery Has Implications for Hep C Research
June 21

Activists Call for Earlier Access to Hep C Treatments
June 16

A Better Way to Detect Infections in Donated Organs
June 16

Noninvasive Liver Tests May Predict Hepatitis C Patient Survival
June 14

Analysis Finds Mortality from All Causes Higher Among Hepatitis C-Infected
June 11

Noninvasive Tests Reduce Need for Liver Biopsies in Hep C
June 11

Scientists Create Humanized Mouse Model for Hepatitis C
June 8

Pharmasset Announces the Expansion of the ELECTRON Trial in Chronic Hepatitis C
June 8

Patient Acceptance of Universal Screening for Hepatitis C Virus Infection
June 7

Shorter Treatment for Acute Hep C Works in HIV-Coinfected MSM
June 2

Videoconferencing Enables PCPs to Deliver Specialist-Quality Hep C Treatment
June 2

Noninvasive Diagnostics May Offer Alternative to Liver Biopsy for Assessing Liver Fibrosis
June 2

Heavy Coffee Consumption Linked to Better Hep C Treatment Response
June 1

Clincial Trial Evaluating 16 and 24 Weeks of a Four-Drug Regimen and 24 Weeks of a Three-Drug Regimen of GS-9451, Peginterferon Alfa 2a (PEG, Pegasys®) and Ribavirin (RBV, Copegus®) With and Without Tegobuvir (GS-9190)
May 28

All-Oral Combination Study with PSI-7977 for HCV Genotypes 1, 2 and 3 Initiated + BMS NS5A BMS-790052
May 26

New Drugs Encouraging for African Americans with Hepatitis C
May 26

The Fair Pricing Coalition Expresses Disappointment at the Price of Vertex’s Newly Approved Hepatitis C Drug
May 25

Arrival of Direct Antiviral Agent Therapy for Hepatitis C Sparks Debate of Who to Treat First
May 25

Gene Associated with Increased Risk of Cirrhosis for HIV/HCV-Co-Infected Patients
May 24

European Approval Recommended for Hepatitis C Drug Boceprevir
May 23

FDA Approves Incivek (Telaprevir) for Hepatitis C
May 23

Merck's Hepatitis C Drug Victrelis Gets Positive Opinion from European Regulator
May 20

Medivir Announces Positive 48-week Interim Data from TMC435 Hepatitis C Phase 2b ASPIRE Study in Treatment-Experienced Genotype-1 Patients
May 20

MK-5172 New Merck Protease Phase 2 Study Starts
May 18

Merck and Roche Establish Strategic Agreements in Fight Against Chronic Hepatitis C
May 17

FDA approves Victrelis for Hepatitis C
May 13

Action Plan to Address the Silent Epidemic of Viral Hepatitis Released by the Department of Health and Human Services
May 13

Diagnosis of Hepatitis C is More Urgent Than Prevention
May 12

UPMC Confirms Patient Got Kidney from Donor with Hepatitis C
May 11

Age-Based Hep C Screening May Work Better Than Risk-Based Screening
May 9

Hepatitis C Cases on Rise among Massachusetts Youth
May 5

Merck & Co’s Victrelis and Vertex’ Telaprevir Get Unanimous Backing from FDA Advisory Panel for Chronic Hep C
Apr 29

FDA Says Vertex Hepatitis Drug is Highly Effective
Apr 27

Merck Pitches Hepatitis C Drug to U.S. FDA Panel
Apr 27

Severity of Hepatitis C and HIV Co-Infection in Mothers Contribute to HCV Transmission to Child
Apr 27

FDA Backs Vertex Hepatitis Drug Efficacy, Shares Jump
Apr 26

FDA Sees Safety Issue with Merck Hepatitis Drug
Apr 25

 On the Long, Hard Road to a Breakthrough
Apr 24

 Idera Pharmaceuticals Delays Initiation of Phase 2 Clinical Trial of IMO-2125 in Treatment-Naïve HCV Patients
Apr 22

 Genetics of Hepatitis C Linked Hepatocellular Carcinoma
Apr 21

 Merck, Vertex Prep
for Hep C Drug Panels

Apr 21

 Transgene, ChronTech Pharma and Inovio Pharmaceuticals to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C
Apr 18

 Quest Diagnostics Launches Hepatitis C Virus Therapy Test Based on IL28B Gene Variants
Apr 18

 New Compounds Show Promise against Hepatitis C Infection
Apr 12

 New Analysis Finds Antidepressants Boost Patient Adherence to Hepatitis C Treatment
Apr 11

 Big picture of how interferon-induced genes launch antiviral defenses revealed
Apr 11

 FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Group's Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
Mar 31

 Inhibitex Reports Positive Safety and Antiviral Data from Its Phase 1b Study of HCV Nucleotide Inhibitor INX-189
Mar 31

 Drug Cocktail Offers New Hope for Hepatitis C Patients
Mar 31

 Presidio Pharmaceuticals, Inc. Announces Positive Results in a Phase 1b Clinical Trial of PPI-461, a Novel, Potent Broadly-Active Hepatitis C Virus (HCV) Inhibitor
Mar 30

 Pharmasset Initiates Phase 2b ATOMIC Trial of PSI-7977 for Multiple HCV Genotypes
Mar 30

 Achillion Announces Positive RVR Results With ACH-1625 to Treat Chronic Hepatitis C
Mar 30

 Santaris Pharma A/S advances miravirsen, the first microRNA-targeted drug to enter clinical trials, into Phase 2 to treat patients infected with Hepatitis C virus
Mar 21

 The Relationship between Body Mass Index and Age at Hepatocellular Carcinoma Onset in HCV-Infected Patients
Mar 17

 Outcomes Differ Among Hepatitis C-Related Vasculitides
Mar 16

 Achillion Granted U.S. Patent for ACH-1625 and Related Protease Inhibitors
Mar 16

 HCSP Launches New Hepatitis and Tattoos Site
Mar 15

 FDA Panel To Review Merck, Vertex Hepatitis Drugs In Late April
Mar 15

 iTherX Initiates Phase 1b Study of First-in-Class Hepatitis C Virus Entry Inhibitor ITX-5061
Mar 15

 Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology
Mar 14

 An Unusually High Cure Rate Recorded after ChronVac-C® Vaccination Followed by Standard Treatment in Patients with Genotype 1 Chronic Hepatitis C
March 8

 Pharmasset Hep C Data Wows Investors
March 8

 New Treatments For Liver Cancer
March 4

 IL28B Gene Predicts Treatment Outcome for Liver Transplantation Patients
March 3

 9 Dayton VA Dental Patients Test Positive for Hepatitis
March 2

 Scripps Pioneers Individualized Medicine by Offering Genetic Testing to Hepatitis C Patients
Feb 25

 SVR Signals Good Prognosis in Decompensated Cirrhosis Due to HCV
Feb 24

 Lack of Health Insurance Limits Hepatitis C Patients' Access to Latest Antiviral Therapy
Feb 24

 New Vaccine Technology Protects Mice from Hepatitis C Virus
Feb 23

 OraSure Technologies Receives FDA Approval for Its OraQuick(R) HCV Rapid Test Using Fingerstick Whole Blood
Feb 22

 Medivir Announces Positive Phase 2b 48-week (SVR24) Interim Results of TMC435 in Treatment-Naive Patients Chronically Infected With Genotype-1 Hepatitis C Virus
Feb 22

 Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 in Adults With Chronic Genotype 1 HCV
Feb 18

 Conatus Pharmaceuticals Initiates Confirmatory Phase 2 Clinical Trial of CTS-1027 for the Treatment of Hepatitis C Virus (HCV)
Feb 17

 U.S. Hepatitis C Cases Down Sharply Since 1980s
Feb 15

 San Francisco Needs a Supervised Injection Clinic
Feb 15

 NVHR: Administration's 2012 Budget Proposal Represents 'Sea Change' in National Response to Viral Hepatitis Epidemic
Feb 14

 Inhibitex Receives Fast Track Designation for INX-189 for the Treatment of Chronic Hepatitis C Infections
Feb 11

 Idenix Pharmaceuticals Provides Updates on Three Clinical Development Programs
Feb 10

 Medivir Announces Start of Phase 1a Trial of the Hepatitis C Polymerase Inhibitor TMC649128
Feb 10

 Study Finds Little Decline in Hepatitis C Infections Among Injection Drug Users
Feb 3

 Study Examines Incident Hepatitis C Infection in HIV-Infected Men
Feb 3

 Illinois Must Pay Damages for Prison Hepatitis Policy
Jan 31

 Researchers Identify Gene Variants Linked to Hepatitis C Treatment-Related Anemia
Jan 25

 Patients Infected with HIV have Higher Drop-Out Rate for Liver Transplantation
Jan 25

 San Francisco Hepatitis C Task Force Releases Recommendations for Fighting Epidemic
Jan 24

 Local Group Helping Find Cure for Hepatitis C
Jan 19

 First Liver Transplant Patients Receive Experimental Drug to Prevent Hepatitis C Infection
Jan 18

 New Hope for Hepatitis C, an Often Hidden Disease
Jan 17

 Complete Response for Advanced Liver Cancer During Sorafenib Therapy: Case Report
Jan 17

 Peregrine Initiates Randomized Phase II Trial of Bavituximab in Chronic Hepatitis C Open-Label Trial Evaluating 12 Weeks of Therapy with Novel Targeted Antibody Bavituximab in Combination With Ribavirin Versus Standard of Care
Jan 10

 Vertex Announces Key Business Objectives To Support Planned Launch of Telaprevir in Hepatitis C and Continued Progress in Other Serious Diseases
Jan 10

 Inhibitex Reports Positive Interim Safety and Antiviral Data from Ongoing Phase 1b Study of HCV Nucleotide Inhibitor INX-189
Jan 10

 Bristol-Myers Squibb and Pharmasset Enter into a Clinical Collaboration Agreement for Proof of Concept Combination Study in Patients Chronically Infected with Hepatitis C
Jan 10

 Hepatitis C: In 2011, a Predictive Marker for Response to Therapy
Jan 7

 Metabolic Syndrome Found in 52 Percent of Patients after Liver Transplantation
Jan 6

 Pharmasset Reports Positive Results from its HCV Clinical Programs
Jan 6

 Boceprevir, Merck's Investigational Oral Hepatitis C Protease Inhibitor, Receives FDA Priority Review and EMA Accelerated Assessment
Jan 6

 

Top News 2010

 INFECTION FILES: Seafood Safety Concerns for Those with Liver Disease
Dec 30

 Scripps Research Scientists Identify Key Interaction In Hepatitis C Virus
Dec 30

 Harm Reduction Moving Mainstream
Dec 27

 Fish Pedicures Could Spread HIV and Hepatitis, Says UAE Ministry of Health
Dec 22

 Vietnamese Pharmaceutical Firm Faces Patent Lawsuit
Dec 22

 Janssen-Cilag Applies for EU Approval of Hepatitis C Drug
Dec 22

 Vertex Provides Update to Ongoing Phase 2 Study Evaluating Combinations of Telaprevir and VX-222 for the Treatment of Hepatitis C
Dec 21

 Infectious Diseases Kill Thousands: Ontario Atudy
Dec 15

 The Voices of Hepatitis
Dec 15

 Hepatitis Experts Create Roadmap for Accelerating the Development of Targeted Therapies for Hepatitis C Virus Dec 14

 National Transplant Medical Experts Insist Arizona Transplant Cuts are Based on Flawed Data Dec 9

 Anemia in Treated-HCV Patients Bodes Well for Sustained Virologic Response Dec 6

 Safe Injection Sites Will Open with or without Permission Dec 1

 On Eve of World Aids Day, Yee Recommits to Sterile Syringe Bill Dec 1

 First-Ever Covalent Irreversible Inhibition of a Protease Central to Hepatitis C Infection Nov 28

 Vertex Completes New Drug Application for Telaprevir for Hepatitis C Nov 23

 Antiviral “Cocktail” Better than Single Drug for Children with Hepatitis C Nov 10

Polymorphism Associated with Good Antiviral Response but Also Depression in HCV Nov 4

 Growth Factor Drugs Bolster Compliance in Hepatitis C Therapy Nov 3

 Abbott Hep C Drug ABT-450/r Impresses in Mid-Stage Trial Nov 2

 Avila Presents New Data on its Novel, Orally-Available Targeted Covalent Drug, AVL-192 Nov 2

 AASLD: HCV 'Cure' Now on Agenda Nov 2

 Final Results of Clinical Trial on Boceprevir Nov 1

 NVHR Welcomes Dr. Koh's Remarks at AASLD, but Warns that Viral Hepatitis Battle Demands Decisive National Leadership Nov 1

 Mortality Rates from Liver Diseases Underestimated Nov 1

 Hep C Update: Vertex, Merck and Gilead Oct 31

 AASLD: Successful HCV Tx Cuts Deaths Post-Transplant Oct 31

 First Human Liver Grown in Lab Oct 29

 Hepatitis C Iincreased Risks for Cerebrovascular-Related Death Oct 28

 

 

Journal Review

June 25, 2010

May 24, 2010

April 28, 2010

March 29, 2010

February 24, 2010

January 24, 2010


2009 News Review Articles

Journal Review

December 22, 2009

November 30, 2009

October 28, 2009

September 28, 2009

August 26, 2009

July 27, 2009

June 29, 2009

May 25, 2009

April 29, 2009

March 25, 2009

February 28, 2009

January 15, 2009

2008 News Review Articles

Journal Review

December 15 , 2008

November 15 , 2008

October 15 , 2008

September 15 , 2008

August 15 , 2008

July 15 , 2008

June 15 , 2008

May 15 , 2008

April 15 , 2008

February 10 , 2008

January 25 , 2008

January 15 , 2008


Top News

Journal Review

Eblast

More Archives


About Hepatitis | News Updates | Community & Support | Resource Library | About HCSP | Contact Us | Site Map | Recursos en Español | Home

Hepatitis C Support Project

© <%=year(date)%> Hepatitis C Support Project

Medical  Writers' Circle
Fact Sheets